Literature DB >> 30030669

Incidence of primary liver cancer in American Indians and Alaska Natives, US, 1999-2009.

Stephanie C Melkonian1, Melissa A Jim2, Brigg Reilley3, Jennifer Erdrich4, Zahava Berkowitz5, Charles L Wiggins6, Donald Haverkamp2, Mary C White5.   

Abstract

PURPOSE: To evaluate liver cancer incidence rates and risk factor correlations in non-Hispanic AI/AN populations for the years 1999-2009.
METHODS: We linked data from 51 central cancer registries with the Indian Health Service patient registration databases to improve identification of the AI/AN population. Analyses were restricted to non-Hispanic persons living in Contract Health Service Delivery Area counties. We compared age-adjusted liver cancer incidence rates (per 100,000) for AI/AN to white populations using rate ratios. Annual percent changes (APCs) and trends were estimated using joinpoint regression analyses. We evaluated correlations between regional liver cancer incidence rates and risk factors using Pearson correlation coefficients.
RESULTS: AI/AN persons had higher liver cancer incidence rates than whites overall (11.5 versus 4.8, RR = 2.4, 95% CI 2.3-2.6). Rate ratios ranged from 1.6 (Southwest) to 3.4 (Northern Plains and Alaska). We observed an increasing trend among AI/AN persons (APC 1999-2009 = 5%). Rates of distant disease were higher in the AI/AN versus white population for all regions except Alaska. Alcohol use (r = 0.84) and obesity (r = 0.79) were correlated with liver cancer incidence by region.
CONCLUSIONS: Findings highlight disparities in liver cancer incidence between AI/AN and white populations and emphasize opportunities to decrease liver cancer risk factor prevalence.

Entities:  

Keywords:  Alaska Native; American Indian; Cancer incidence; Health disparity; Liver cancer

Mesh:

Year:  2018        PMID: 30030669      PMCID: PMC6108913          DOI: 10.1007/s10552-018-1059-3

Source DB:  PubMed          Journal:  Cancer Causes Control        ISSN: 0957-5243            Impact factor:   2.506


  31 in total

1.  Outcomes of treatment for hepatitis C virus infection by primary care providers.

Authors:  Sanjeev Arora; Karla Thornton; Glen Murata; Paulina Deming; Summers Kalishman; Denise Dion; Brooke Parish; Thomas Burke; Wesley Pak; Jeffrey Dunkelberg; Martin Kistin; John Brown; Steven Jenkusky; Miriam Komaromy; Clifford Qualls
Journal:  N Engl J Med       Date:  2011-06-01       Impact factor: 91.245

2.  Racial misclassification of American Indians and Alaska Natives by Indian Health Service Contract Health Service Delivery Area.

Authors:  Melissa A Jim; Elizabeth Arias; Dean S Seneca; Megan J Hoopes; Cheyenne C Jim; Norman J Johnson; Charles L Wiggins
Journal:  Am J Public Health       Date:  2014-04-22       Impact factor: 9.308

3.  Alcohol-attributable mortality among American Indians and Alaska Natives in the United States, 1999-2009.

Authors:  Michael Landen; Jim Roeber; Tim Naimi; Larry Nielsen; Mack Sewell
Journal:  Am J Public Health       Date:  2014-04-22       Impact factor: 9.308

4.  Elimination of hepatocellular carcinoma and acute hepatitis B in children 25 years after a hepatitis B newborn and catch-up immunization program.

Authors:  Brian J McMahon; Lisa R Bulkow; Rosalyn J Singleton; James Williams; Mary Snowball; Chriss Homan; Alan J Parkinson
Journal:  Hepatology       Date:  2011-07-19       Impact factor: 17.425

5.  Hepatitis C-related hepatocellular carcinoma in the United States: influence of ethnic status.

Authors:  Adrian M Di Bisceglie; Andre C Lyra; Myron Schwartz; Rajender K Reddy; Paul Martin; Gregory Gores; Anna S F Lok; Khozema B Hussain; Robert Gish; David H Van Thiel; Zobair Younossi; Myron Tong; Tarek Hassanein; Luis Balart; Jacquelyn Fleckenstein; Stephen Flamm; Andres Blei; Alex S Befeler
Journal:  Am J Gastroenterol       Date:  2003-09       Impact factor: 10.864

6.  Hepatitis C infection and risk of diabetes: a systematic review and meta-analysis.

Authors:  Donna L White; Vlad Ratziu; Hashem B El-Serag
Journal:  J Hepatol       Date:  2008-08-21       Impact factor: 25.083

7.  Synergism of alcohol, diabetes, and viral hepatitis on the risk of hepatocellular carcinoma in blacks and whites in the U.S.

Authors:  Jian-Min Yuan; Sugantha Govindarajan; Kazuko Arakawa; Mimi C Yu
Journal:  Cancer       Date:  2004-09-01       Impact factor: 6.860

8.  The changing epidemiology and aetiology of hepatocellular carcinoma from 1969 through 2013 in Alaska Native people.

Authors:  Marc Connelly; Michael G Bruce; Lisa Bulkow; Mary Snowball; Brian J McMahon
Journal:  Liver Int       Date:  2016-06-16       Impact factor: 5.828

9.  Methods for improving cancer surveillance data in American Indian and Alaska Native populations.

Authors:  David K Espey; Charles L Wiggins; Melissa A Jim; Barry A Miller; Christopher J Johnson; Tom M Becker
Journal:  Cancer       Date:  2008-09-01       Impact factor: 6.860

10.  Case completeness and data accuracy in the Centers for Disease Control and Prevention's National Program of Cancer Registries.

Authors:  Kathleen K Thoburn; Robert R German; Mary Lewis; Phyllis Janie Nichols; Faruque Ahmed; Jeannette Jackson-Thompson
Journal:  Cancer       Date:  2007-04-15       Impact factor: 6.860

View more
  9 in total

1.  Disparities in Cancer Incidence and Trends among American Indians and Alaska Natives in the United States, 2010-2015.

Authors:  Stephanie C Melkonian; Melissa A Jim; Donald Haverkamp; Charles L Wiggins; Jeffrey McCollum; Mary C White; Judith S Kaur; David K Espey
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2019-10       Impact factor: 4.254

2.  Disparities in Hepatocellular Carcinoma Incidence, Stage, and Survival: A Large Population-Based Study.

Authors:  Yvonne N Flores; Geetanjali D Datta; Liu Yang; Edgar Corona; Divya Devineni; Beth A Glenn; Roshan Bastani; Folasade P May
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2021-03-18       Impact factor: 4.254

3.  Long-Term Trends of Liver Cancer Incidence and Mortality in China 1990-2017: A Joinpoint and Age-Period-Cohort Analysis.

Authors:  Fang Wang; Sumaira Mubarik; Yu Zhang; Lu Wang; Yafeng Wang; Chuanhua Yu; Hao Li
Journal:  Int J Environ Res Public Health       Date:  2019-08-12       Impact factor: 3.390

4.  Incidence of and Trends in the Leading Cancers With Elevated Incidence Among American Indian and Alaska Native Populations, 2012-2016.

Authors:  Stephanie C Melkonian; Hannah K Weir; Melissa A Jim; Bailey Preikschat; Donald Haverkamp; Mary C White
Journal:  Am J Epidemiol       Date:  2021-04-06       Impact factor: 4.897

5.  miR-10b-5p Suppresses the Proliferation and Invasion of Primary Hepatic Carcinoma Cells by Downregulating EphA2.

Authors:  Xu Niu; Haitao Sun; Feng Qiu; Jing Liu; Tianchi Yang; Wei Han
Journal:  Biomed Res Int       Date:  2021-12-29       Impact factor: 3.411

6.  Renal Cell Carcinoma Surgical Treatment Disparities in American Indian/Alaska Natives and Hispanic Americans in Arizona.

Authors:  Francine C Gachupin; Benjamin R Lee; Juan Chipollini; Kathryn R Pulling; Alejandro Cruz; Ava C Wong; Celina I Valencia; Chiu-Hsieh Hsu; Ken Batai
Journal:  Int J Environ Res Public Health       Date:  2022-01-21       Impact factor: 3.390

Review 7.  A Review of Current and Emerging Therapies for Advanced Hepatocellular Carcinoma.

Authors:  Angelica Singh; Sofia Zahid; Ilya Noginskiy; Timothy Pak; Soeb Usta; Marina Barsoum; Uqba Khan
Journal:  Curr Oncol       Date:  2022-09-08       Impact factor: 3.109

8.  Racial and Ethnic Disparities in Survival Among Patients With Hepatocellular Carcinoma in the United States: A Systematic Review and Meta-Analysis.

Authors:  Nicole E Rich; Christian Carr; Adam C Yopp; Jorge A Marrero; Amit G Singal
Journal:  Clin Gastroenterol Hepatol       Date:  2020-12-30       Impact factor: 11.382

9.  Gastric Cancer Among American Indian and Alaska Native Populations in the United States, 2005-2016.

Authors:  Stephanie C Melkonian; Dornell Pete; Melissa A Jim; Donald Haverkamp; Charles L Wiggins; Michael G Bruce; Mary C White
Journal:  Am J Gastroenterol       Date:  2020-12       Impact factor: 12.045

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.